Status
Terminated
Drug Enforcement D-0060-2023
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Classification
Class II
Report Date
November 23, 2022
Termination Date
August 23, 2023
Product Information
- Product description
- Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
- Product quantity
- 960 bottles
- Reason for recall
- Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
- Recall initiation reason
- —
- Initial firm notification
- Letter
- Distribution pattern
- Nationwide in the USA
Location & Firm
- Recalling firm
- ImprimisRx NJ
- Address
-
1705 Us Highway 46 Ste 4, N/A
United States - Voluntary / Mandated
- Voluntary: Firm initiated
- Status date
- —
Codes & Dates
- Recall number
- D-0060-2023
- Event ID
- 91140
- Recall initiation date
- November 9, 2022
- Center classification date
- November 14, 2022
- Code info
- Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023
- More code info
- —